Belkyra

Belkyra (Deoxycholic Acid) is a prescription medication used for subcutaneous use. It is designed to reduce moderate to severe convexity or fullness associated with submental fat. This treatment is administered by healthcare professionals.

Belkyra is primarily used for the reduction of submental fat, commonly known as a double chin. It works by destroying fat cells in the treatment area, which are then naturally processed and eliminated by the body. This medication is often sought by individuals looking to improve their facial profile and reduce the appearance of submental fullness.

Common effects of Belkyra may include swelling, bruising, pain, numbness, redness, and areas of hardness in the treatment area. These effects are typically temporary and resolve within a few weeks. Some individuals may also experience headache, nausea, or facial weakness.

Belkyra should be administered by a healthcare professional with experience in the procedure. It is important to discuss your medical history and any current medications with your healthcare provider before treatment. Avoid touching or massaging the treatment area for several days after the procedure.

Belkyra may interact with other medications or substances. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Avoid alcohol and other substances that may increase the risk of bleeding or bruising.